These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 7655032
1. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Sands MS, Erway LC, Vogler C, Sly WS, Birkenmeier EH. Blood; 1995 Sep 01; 86(5):2033-40. PubMed ID: 7655032 [Abstract] [Full Text] [Related]
2. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS, Birkenmeier E. Lab Invest; 1993 Jun 01; 68(6):676-86. PubMed ID: 8515654 [Abstract] [Full Text] [Related]
3. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease. Vogler C, Sands MS, Galvin N, Levy B, Thorpe C, Barker J, Sly WS. J Inherit Metab Dis; 1998 Aug 01; 21(5):575-86. PubMed ID: 9728337 [Abstract] [Full Text] [Related]
4. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. Freeman BJ, Roberts MS, Vogler CA, Nicholes A, Hofling AA, Sands MS. Blood; 1999 Sep 15; 94(6):2142-50. PubMed ID: 10477745 [Abstract] [Full Text] [Related]
5. Inner ear pathology in the mucopolysaccharidosis VII mouse. Ohlemiller KK, Hennig AK, Lett JM, Heidbreder AF, Sands MS. Hear Res; 2002 Jul 15; 169(1-2):69-84. PubMed ID: 12121741 [Abstract] [Full Text] [Related]
6. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. O'Connor LH, Erway LC, Vogler CA, Sly WS, Nicholes A, Grubb J, Holmberg SW, Levy B, Sands MS. J Clin Invest; 1998 Apr 01; 101(7):1394-400. PubMed ID: 9525982 [Abstract] [Full Text] [Related]
7. Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation. Ohlemiller KK, Vogler CA, Roberts M, Galvin N, Sands MS. Exp Eye Res; 2000 Nov 01; 71(5):469-81. PubMed ID: 11040082 [Abstract] [Full Text] [Related]
8. Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency. Soper BW, Lessard MD, Vogler CA, Levy B, Beamer WG, Sly WS, Barker JE. Blood; 2001 Mar 01; 97(5):1498-504. PubMed ID: 11222399 [Abstract] [Full Text] [Related]
9. Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages. Ohashi T, Yokoo T, Iizuka S, Kobayashi H, Sly WS, Eto Y. Blood; 2000 Jun 01; 95(11):3631-3. PubMed ID: 10828055 [Abstract] [Full Text] [Related]
10. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. Sands MS, Vogler C, Kyle JW, Grubb JH, Levy B, Galvin N, Sly WS, Birkenmeier EH. J Clin Invest; 1994 Jun 01; 93(6):2324-31. PubMed ID: 8200966 [Abstract] [Full Text] [Related]
11. Pathology of the ear in murine mucopolysaccharidosis type VII. Morphologic correlates of hearing loss. Berry CL, Vogler C, Galvin NJ, Birkenmeier EH, Sly WS. Lab Invest; 1994 Sep 01; 71(3):438-45. PubMed ID: 7933993 [Abstract] [Full Text] [Related]
12. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice. Sakurai K, Iizuka S, Shen JS, Meng XL, Mori T, Umezawa A, Ohashi T, Eto Y. Gene Ther; 2004 Oct 01; 11(19):1475-81. PubMed ID: 15295619 [Abstract] [Full Text] [Related]
13. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII. Derrick-Roberts AL, Pyragius CE, Kaidonis XM, Jackson MR, Anson DS, Byers S. Hum Gene Ther; 2014 Sep 01; 25(9):798-810. PubMed ID: 25003807 [Abstract] [Full Text] [Related]
14. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice. Hennig AK, Ogilvie JM, Ohlemiller KK, Timmers AM, Hauswirth WW, Sands MS. Mol Ther; 2004 Jul 01; 10(1):106-16. PubMed ID: 15233947 [Abstract] [Full Text] [Related]
15. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y. J Neurosci Res; 2003 Oct 15; 74(2):266-77. PubMed ID: 14515356 [Abstract] [Full Text] [Related]
16. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. Sands MS, Vogler C, Torrey A, Levy B, Gwynn B, Grubb J, Sly WS, Birkenmeier EH. J Clin Invest; 1997 Apr 01; 99(7):1596-605. PubMed ID: 9120003 [Abstract] [Full Text] [Related]
17. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS. Gene Ther; 2001 Sep 01; 8(17):1291-8. PubMed ID: 11571565 [Abstract] [Full Text] [Related]
18. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Birkenmeier EH, Barker JE, Vogler CA, Kyle JW, Sly WS, Gwynn B, Levy B, Pegors C. Blood; 1991 Dec 01; 78(11):3081-92. PubMed ID: 1954394 [Abstract] [Full Text] [Related]
19. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Vogler C, Sands MS, Levy B, Galvin N, Birkenmeier EH, Sly WS. Pediatr Res; 1996 Jun 01; 39(6):1050-4. PubMed ID: 8725268 [Abstract] [Full Text] [Related]
20. Gene therapy for murine mucopolysaccharidosis type VII. Sands MS, Wolfe JH, Birkenmeier EH, Barker JE, Vogler C, Sly WS, Okuyama T, Freeman B, Nicholes A, Muzyczka N, Chang PL, Axelrod HR. Neuromuscul Disord; 1997 Jul 01; 7(5):352-60. PubMed ID: 9267850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]